Arda Therapeutics
San Carlos, California, United States · Biotechnology · 200 employees
Arda Therapeutics is pioneering the use of targeted cell depletion to treat chronic diseases. By identifying and selectively depleting pathogenic cells, Arda aims to develop therapies that offer greater efficacy, faster discovery timelines and reduced dosing frequency compared to traditional approaches. With a world-class team and a robust pipeline, Arda is poised to transform the landscape of chr
Funding history
- Venture - Series Unknown — $43.3M — Oct 2024
- Venture - Series Unknown — $7.5M — Jan 2022
Recent signals
- Oct 09, 2024: Arda Therapeutics Appoints Scott Turner as Chief Scientific Officer
- Oct 02, 2024: Raised $43.3M in Venture - Series Unknown
- Jan 14, 2022: Raised $7.5M in Venture - Series Unknown
See plans & pricing → Track Arda Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.